Subscribe To
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
United therapeutics corporation (uthr) q3 2023 earnings call transcript
United Therapeutics Corporation (NASDAQ:UTHR ) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Company Participants Dewey Steadman – He...
November 1, 2023, 2:38 pm
transplant diagnostics market surges at 7.2% cagr towards usd 8.3 billion by 2032 | market.us
In 2022, molecular assays led in technology, reagents topped product & service, solid organ transplants...
October 19, 2023, 1:52 pm
Transmedics group: a company in flux
Today, we put the focus on TransMedics Group, Inc., a healthcare company focused on transforming the organ transport and ...
October 18, 2023, 3:25 pm
Transmedics: transforming the landscape, but no rush to buy
TransMedics is a medical tech company focused on organ transplants in the US. TMDX looks set to be a ke...
October 18, 2023, 9:19 am
Hla typing market: projected expansion to reach usd 2.2 billion by 2032, sustaining a consistent 6.4% cagr
The market is growing due to increased organ transplant methods, higher demand for diagnostic products,...
October 17, 2023, 1:21 pm
Eu regulator backs merck's viral infection drug
European health regulator backed Merck & Co's drug to treat a type of infection in adult kidney transplant...
October 17, 2023, 7:06 am
Down more than 50% since july, this incredible growth stock is a screaming buy on the dip
Hospitals and transplant centers increasingly rely on TransMedics Group to retrieve donated hearts, lun...
October 14, 2023, 5:37 am
Eledon pharmaceuticals to present data from ongoing phase 1b trial of tegoprubart in patients undergoing kidney transplantation at the american society of nephrology kidney week 2023 annual meeting
IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will pr...
October 13, 2023, 11:00 am
Miromatrix to present at the 2023 isodp organ donation congress
EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology ...
October 11, 2023, 8:05 pm
Miromatrix ceo jeff ross to present at the 2023 cell & gene meeting on the mesa
EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology f...
October 5, 2023, 4:30 pm
Neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy
Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory interneuron ce...
October 5, 2023, 3:00 pm
Be the match raises $1.1 million at annual gala
Funds raised support saving more lives through blood stem cell transplants MINNEAPOLIS, Oct. 05, 2023 (...
October 5, 2023, 1:18 pm
Jasper therapeutics to present new positive data on briquilimab conditioning in patients with fanconi anemia at the 2023 fanconi anemia research fund scientific symposium
REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
September 21, 2023, 8:00 am
My shortness of breath from congestive heart failure was shrugged off by my doctor — i was told to lose weight. now i’ve learned to advocate for myself.
My doctor blamed my breathlessness on my weight when I needed a heart transplant — now I’ve learned...
September 18, 2023, 2:59 pm
Assessing biolinerx as a buy after drug approval
BioLineRx has received approval for their stem cell mobilizing compound, motixafortide, for certain forms of blood cancer. The compound has shown impr...
September 18, 2023, 1:28 am
Cytosorb with ex vivo organ perfusion: transforming the future of solid organ transplantation
In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant in...
September 11, 2023, 3:32 pm